Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(1356).(12).ENT Case No 87. Vertigo (etiology undetermined) with sleep disturbance; raised BP reading and mild tachycardia. (Prescription 1) 1190

Prescription attached:-

đŸŠē Prescription Analysis & Clinical Working Diagnosis

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ, āĻ“āώ⧁āϧ⧇āϰ āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ āĻāĻŦāĻ‚ āĻšā§‚ā§œāĻžāĻ¨ā§āϤ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ

Author: Md. Rafiqul Islam Lipu

Date: Tuesday, 13 October 2026 (āĻŽāĻ™ā§āĻ—āϞāĻŦāĻžāϰ, ā§§ā§Š āĻ…āĻ•ā§āĻŸā§‹āĻŦāϰ ⧍ā§Ļ⧍ā§Ŧ)

Time: 09:46 PM (Bangladesh Time)

Clinical References: Harrison’s Principles of Internal Medicine, 22nd Edition; Davidson’s Principles and Practice of Medicine, 25th Edition; Katzung’s Basic & Clinical Pharmacology, 16th Edition; NICE Guidelines; MedEx Bangladesh.

Prescription Review Note: āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āϜāĻžā§ŸāĻ—āĻžā§Ÿ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟāĨ¤ āϝ⧇āϗ⧁āϞ⧋ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝāĻ­āĻžāĻŦ⧇ āĻĒ⧜āĻž āϝāĻžāĻšā§āϛ⧇, āϏ⧇āϗ⧁āϞ⧋ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āĻ›āĻŋāĨ¤ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ āĻ…āĻ‚āĻļ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻĒāĻžāĻ  āĻĻāĻŋā§Ÿā§‡āĻ›āĻŋ, āĻ•āĻŋāĻ¨ā§āϤ⧁ āϏ⧇āϗ⧁āϞ⧋āϕ⧇ āύāĻŋāĻļā§āϚāĻŋāϤ āϤāĻĨā§āϝ āĻšāĻŋāϏ⧇āĻŦ⧇ āωāĻĒāĻ¸ā§āĻĨāĻžāĻĒāύ āĻ•āϰāĻŋāύāĻŋāĨ¤ āĻļ⧁āϧ⧁ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻĻ⧇āϖ⧇ āϰ⧋āϗ⧇āϰ āĻ•āĻžāϰāĻŖ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤


1. Patient Information — āϰ⧋āĻ—ā§€āϰ āϤāĻĨā§āϝ

āĻŦāĻŋāώ⧟ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϤāĻĨā§āϝ
Hospital āωāĻĒāĻœā§‡āϞāĻž āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻ•āĻŽāĻĒā§āϞ⧇āĻ•ā§āϏ, āĻŽāĻĻāύ, āύ⧇āĻ¤ā§āϰāϕ⧋āĻŖāĻž
Department Outpatient Department (āĻŦāĻšāĻŋāĻ°ā§āĻŦāĻŋāĻ­āĻžāĻ—)
Age (āĻŦ⧟āϏ) āφāύ⧁āĻŽāĻžāύāĻŋāĻ• ā§Ģā§Ļ āĻŦāĻ›āϰ
Sex (āϞāĻŋāĻ™ā§āĻ—) āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āωāĻ˛ā§āϞ⧇āĻ– āύ⧇āχ
Patient Name āĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ
Prescribing Physician āϏāĻŋāϞ āĻ…āύ⧁āϝāĻžā§Ÿā§€ Dr. Nurul Huda
Prescription Date āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟

2. C/C — Chief Complaints (āĻĒā§āϰāϧāĻžāύ āĻ…āĻ­āĻŋāϝ⧋āĻ—)

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļ⧇ āϰ⧋āϗ⧇āϰ āĻŦāĻŋāĻŦāϰāĻŖ āĻ…āĻ‚āĻļ⧇ āϤāĻŋāύāϟāĻŋ āĻŦāĻŋāώ⧟ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇āĨ¤

C/C English āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ Confidence
1 Vertigo āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻŦāĻž āϚāĻžāϰāĻĒāĻžāĻļ āϘ⧁āϰāϛ⧇ āĻŦāϞ⧇ āĻ…āύ⧁āĻ­ā§‚āϤ āĻšāĻ“ā§ŸāĻž 98%
2 Decreased Sleep āϘ⧁āĻŽ āĻ•āĻŽ āĻšāĻ“ā§ŸāĻž āĻŦāĻž āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž 98%
3 DM (−) āϏāĻŽā§āĻ­āĻŦāϤ āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āύ⧇āχ 80%

Clinical Interpretation — āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž

1. Vertigo — āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž

Vertigo āĻŦāϞāϤ⧇ āϰ⧋āĻ—ā§€āϰ āύāĻŋāĻœā§‡āϰ āĻļāϰ⧀āϰ āĻ…āĻĨāĻŦāĻž āϚāĻžāϰāĻĒāĻžāĻļ āϘ⧁āϰāϛ⧇ āĻŦāϞ⧇ āĻ…āύ⧁āĻ­ā§‚āϤ āĻšāĻ“ā§ŸāĻžāϕ⧇ āĻŦā§‹āĻāĻžā§ŸāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāϪ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ°ā§Ÿā§‡āϛ⧇:

  • Benign Paroxysmal Positional Vertigo (BPPV)
  • Vestibular neuritis
  • MÊnière’s disease
  • Vestibular migraine
  • Central vestibular disorders

āĻ āĻ›āĻžā§œāĻž āϰ⧋āĻ—ā§€ āϝāĻĻāĻŋ āĻĒā§āϰāĻ•ā§ƒāϤ āĻ˜ā§‚āĻ°ā§āĻŖāύ⧇āϰ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤ⧇ āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻ•āĻž āϞāĻžāĻ—āĻž āĻŦā§‹āĻāĻžāύ, āϤāĻžāĻšāϞ⧇ Orthostatic hypotension, cardiac arrhythmia āĻ…āĻĨāĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ•āĻžāϰāĻŖ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

2. Decreased Sleep — āϘ⧁āĻŽ āĻ•āĻŽ āĻšāĻ“ā§ŸāĻž

āĻāϟāĻŋ Insomnia-āĻāϰ āĻāĻ•āϟāĻŋ āωāĻĒāϏāĻ°ā§āĻ— āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻ•āϤāĻĻāĻŋāύ āϧāϰ⧇ āϘ⧁āĻŽ āĻ•āĻŽ āĻšāĻšā§āϛ⧇ āĻāĻŦāĻ‚ āĻĻ⧈āύāĻ¨ā§āĻĻāĻŋāύ āĻ•āĻžāĻœā§‡ āĻĒā§āϰāĻ­āĻžāĻŦ āĻĒ⧜āϛ⧇ āĻ•āĻŋ āύāĻž, āϤāĻž āύāĻž āĻœā§‡āύ⧇ Chronic Insomnia Disorder āĻŦāϞāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

3. DM (−) — Diabetes Mellitus Negative

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϏāĻŽā§āĻ­āĻŦāϤ āϰ⧋āĻ—ā§€āϰ āĻĒā§‚āĻ°ā§āĻŦ⧇ āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ āύāĻž āĻĨāĻžāĻ•āĻžāϰ āχāϤāĻŋāĻšāĻžāϏ āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤

āĻāϟāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ āύ⧇āĻ‡â€”āĻāĻŽāύ āĻĒā§āϰāĻŽāĻžāĻŖ āύ⧟āĨ¤

Textbook Reference: Harrison’s Principles of Internal Medicine, 22nd Edition, Chapter 24: Dizziness and Vertigo.


3. O/E — On Examination (āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āĻĒā§āϰāĻžāĻĒā§āϤ āϤāĻĨā§āϝ)

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻ…āĻ‚āĻļ⧇ āĻĻ⧁āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ Vital Sign āϞ⧇āĻ–āĻž āφāϛ⧇āĨ¤

Parameter Recorded Finding Clinical Interpretation
Blood Pressure 144/99 mmHg Elevated blood pressure — āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āϰāĻŋāĻĄāĻŋāĻ‚
Pulse Rate 103/min Tachycardia — āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāϕ⧇āϰ āϤ⧁āϞāύāĻžā§Ÿ āĻĻā§āϰ⧁āϤ āĻĒāĻžāϞāϏ

A. Blood Pressure: 144/99 mmHg

Clinical Assessment: Elevated Blood Pressure

NICE NG136 āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻ•ā§āϞāĻŋāύāĻŋāϕ⧇ BP â‰Ĩ140/90 mmHg āĻšāϞ⧇ āĻĒ⧁āύāϰāĻžā§Ÿ āĻŽāĻžāĻĒāϤ⧇ āĻšāĻŦ⧇ āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ ABPM/HBPM āĻĻāĻŋā§Ÿā§‡ Hypertension āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

āϏ⧁āϤāϰāĻžāĻ‚ āĻāĻ–āĻžāύ⧇:

  • āϰāĻ•ā§āϤāϚāĻžāĻĒ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāϕ⧇āϰ āĻšā§‡ā§Ÿā§‡ āĻŦ⧇āĻļāĻŋāĨ¤
  • āĻāĻ•āϟāĻŋ āϰāĻŋāĻĄāĻŋāĻ‚ āĻĻāĻŋā§Ÿā§‡ āĻ¸ā§āĻĨāĻžā§Ÿā§€ Hypertension āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤
  • āφāϗ⧇ āĻĨ⧇āϕ⧇ āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ āφāϛ⧇ āĻ•āĻŋ āύāĻž āϜāĻžāύāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤
  • āϰ⧋āĻ—ā§€āϰ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āĻ•āĻžāϰāĻŖ āĻļ⧁āϧ⧁ BP āϧāϰ⧇ āύ⧇āĻ“ā§ŸāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Confidence: 98% — āϝāĻĻāĻŋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϰāĻŋāĻĄāĻŋāĻ‚ 144/99 āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻĒ⧜āĻž āĻšā§Ÿā§‡ āĻĨāĻžāϕ⧇āĨ¤

B. Pulse Rate: 103/min

Clinical Assessment: Tachycardia

āĻĒā§āϰāĻžāĻĒā§āϤāĻŦ⧟āĻ¸ā§āĻ• āĻŦā§āϝāĻ•ā§āϤāĻŋāϰ āĻŦāĻŋāĻļā§āϰāĻžāĻŽāĻ•āĻžāϞ⧀āύ āĻĒāĻžāϞāϏ āϏāĻžāϧāĻžāϰāĻŖāϤ 60–100/mināĨ¤

āĻāĻ–āĻžāύ⧇ 103/min āĻšāĻ“ā§ŸāĻžā§Ÿ āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āĻŦ⧇āĻļāĻŋāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ:

  • Anxiety — āωāĻĻā§āĻŦ⧇āĻ—
  • Dehydration — āĻĒāĻžāύāĻŋāĻļā§‚āĻ¨ā§āϝāϤāĻž
  • Pain or physiological stress — āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻļāĻžāϰ⧀āϰāĻŋāĻ• āϚāĻžāĻĒ
  • Anemia — āϰāĻ•ā§āϤāĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻž
  • Hyperthyroidism — āĻĨāĻžāχāĻ°ā§Ÿā§‡āĻĄ āĻšāϰāĻŽā§‹āύ āĻŦā§‡ā§œā§‡ āϝāĻžāĻ“ā§ŸāĻž
  • Cardiac arrhythmia — āĻšā§ƒāĻĻā§â€ŒāĻ¸ā§āĻĒāĻ¨ā§āĻĻāύ⧇āϰ āĻ›āĻ¨ā§āĻĻ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž

āĻŦāĻŋāĻļ⧇āώ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ: Pulse 103/min āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇āĻ“ ECG āύāĻž āĻĻ⧇āϖ⧇ Sinus Tachycardia āύāĻŋāĻļā§āϚāĻŋāϤ āĻŦāϞāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤


4. Patient History — āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϕ⧀ āϕ⧀ āχāϤāĻŋāĻšāĻžāϏ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āϛ⧇āύ?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϤāĻĨā§āϝāϗ⧁āϞ⧋:

History Documentation
Vertigo ✓ Mentioned
Sleep disturbance ✓ Mentioned
Diabetes mellitus āϏāĻŽā§āĻ­āĻŦāϤ Negative
Hypertension history Not mentioned
Previous stroke/TIA Not mentioned
Hearing loss Not mentioned
Tinnitus Not mentioned
Nausea/Vomiting Not mentioned
Headache/Migraine Not mentioned
Drug history Not mentioned
Allergy history Not mentioned
Duration of symptoms Not clearly mentioned

āĻāĻ–āĻžāύ⧇ Not mentioned āĻ…āĻ°ā§āĻĨ āϰ⧋āĻ—ā§€āϰ āϏāĻŽāĻ¸ā§āϝāĻž āύ⧇āχ āύ⧟; āĻŦāϰāĻ‚ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϤāĻĨā§āϝāϟāĻŋ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

Clinical Concern

Vertigo āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āχāϤāĻŋāĻšāĻžāϏāϗ⧁āϞ⧋āϰ āĻāĻ•āϟāĻŋ āĻšāϞ⧋:

āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϟāĻž āĻ•āĻŋ āĻŦāĻŋāĻ›āĻžāύāĻžā§Ÿ āĻĒāĻžāĻļ āĻĢāĻŋāϰāϞ⧇ āĻŦāĻž āĻŽāĻžāĻĨāĻžāϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻ•āϰāϞ⧇ āĻļ⧁āϰ⧁ āĻšā§Ÿ, āύāĻžāĻ•āĻŋ āĻāĻ•āϟāĻžāύāĻž āĻĨāĻžāϕ⧇?

āĻāχ āϤāĻĨā§āϝ āĻ›āĻžā§œāĻž BPPV, vestibular neuritis āĻāĻŦāĻ‚ central vertigo-āĻāϰ āĻŽāĻ§ā§āϝ⧇ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤


5. Investigation Analysis — āĻĒāϰ⧀āĻ•ā§āώāĻž-āύāĻŋāϰ⧀āĻ•ā§āώāĻžāϰ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ Adv. āĻ…āĻ‚āĻļ⧇ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āύāĻžāĻŽ āĻ“ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻĢāϞ āϞ⧇āĻ–āĻž āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻ…āύ⧁āϝāĻžā§Ÿā§€:

Investigation āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ Recorded Finding Clinical Interpretation
Serum Creatinine / āĻ…āĻ¨ā§āϝ Serum Test 0.6 āĻŦāĻž 10.6-āĻāϰ āĻŽāϤ⧋; āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āύāĻžāĻŽ āĻ“ āĻŽāĻžāύ āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟
ECG N (Normal) āϏāĻŽā§āĻ­āĻŦāϤ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• ECG
CBC 12.4 āĻāĻŦāĻ‚ 20 āϕ⧋āύ āĻŽāĻžāύ āϕ⧋āύ āĻĒā§āϝāĻžāϰāĻžāĻŽāĻŋāϟāĻžāϰ⧇āϰ, āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟
RBS 6.8 Random Blood Sugar āĻšāϤ⧇ āĻĒāĻžāϰ⧇; āĻāĻ•āĻ• āϞ⧇āĻ–āĻž āύ⧇āχ

1. ECG — Electrocardiogram

āĻŦāĻžāĻ‚āϞāĻž: āĻšā§ƒāĻĻā§â€ŒāϝāĻ¨ā§āĻ¤ā§āϰ⧇āϰ āĻŦ⧈āĻĻā§āϝ⧁āϤāĻŋāĻ• āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽ āĻĒāϰ⧀āĻ•ā§āώāĻžāĨ¤

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ ECG-āĻāϰ āĻĒāĻžāĻļ⧇ āĻāĻ•āϟāĻŋ āĻŦ⧃āĻ¤ā§āϤ⧇āϰ āĻŽāĻ§ā§āϝ⧇ N āĻĻ⧇āĻ–āĻž āϝāĻžāĻšā§āϛ⧇āĨ¤

āϏāĻŽā§āĻ­āĻŦāϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• ECG Normal āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤

āϤāĻŦ⧇ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• ECG āĻĨāĻžāĻ•āϞ⧇āĻ“ āĻŽāĻžāĻā§‡āĻŽāĻ§ā§āϝ⧇ āĻšāĻ“ā§ŸāĻž Arrhythmia āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻžāĻĻ āĻĻ⧇āĻ“ā§ŸāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

2. CBC — Complete Blood Count

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§‚āĻ°ā§āĻŖāĻžāĻ™ā§āĻ— āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻžāĨ¤

āϏāĻŽā§āĻ­āĻŦāϤ CBC-āĻāϰ āĻĒāĻžāĻļ⧇ 12.4 āĻāĻŦāĻ‚ 20 āϞ⧇āĻ–āĻž āφāϛ⧇āĨ¤

12.4 āϝāĻĻāĻŋ Hemoglobin (Hb) āĻšā§Ÿ, āϤāĻžāĻšāϞ⧇ āϰ⧋āĻ—ā§€āϰ āϞāĻŋāĻ™ā§āĻ— āĻ“ āĻ˛ā§āϝāĻžāĻŦ⧇āϰ Reference Range āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

20 āϏāĻ‚āĻ–ā§āϝāĻžāϟāĻŋ ESR āĻ•āĻŋ āύāĻž, āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

3. RBS — Random Blood Sugar

āĻŦāĻžāĻ‚āϞāĻž: āϝ⧇āϕ⧋āύ⧋ āϏāĻŽā§Ÿā§‡ āϰāĻ•ā§āϤ⧇ āĻ—ā§āϞ⧁āϕ⧋āĻœā§‡āϰ āĻŽāĻžāĻ¤ā§āϰāĻžāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŽāĻžāύ: 6.8āĨ¤

āϝāĻĻāĻŋ āĻāĻ•āĻ• mmol/L āĻšā§Ÿ, āϤāĻžāĻšāϞ⧇ āĻāϟāĻŋ āĻāĻ•āĻž āĻĄāĻžā§ŸāĻžāĻŦ⧇āϟāĻŋāϏ āύāĻŋāĻ°ā§āĻŖā§Ÿā§‡āϰ āϜāĻ¨ā§āϝ āϝāĻĨ⧇āĻˇā§āϟ āύ⧟āĨ¤ āĻāĻ•āĻ• āύāĻŋāĻļā§āϚāĻŋāϤ āύāĻž āĻšāϞ⧇ āĻĢāϞāϟāĻŋāϰ āĻšā§‚ā§œāĻžāĻ¨ā§āϤ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

4. Serum Test

āĻĒā§āϰāĻĨāĻŽ āϞāĻžāχāύ⧇āϰ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āύāĻžāĻŽ āĻāĻŦāĻ‚ āĻĢāϞ āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āĻĒ⧜āĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

āĻāϟāĻŋ Serum Creatinine āĻŦāĻž āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ Serum Investigation āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Clinical Decision: āĻŽā§‚āϞ āĻ˛ā§āϝāĻžāĻŦāϰ⧇āϟāϰāĻŋ āϰāĻŋāĻĒā§‹āĻ°ā§āϟ āĻ›āĻžā§œāĻž āĻ•āĻŋāĻĄāύāĻŋ, āĻ•ā§āϝāĻžāϞāϏāĻŋ⧟āĻžāĻŽ āĻŦāĻž āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āĻŦāĻžā§Ÿā§‹āϕ⧇āĻŽāĻŋāĻ•ā§āϝāĻžāϞ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āϤāĻž āύāĻŋāĻ°ā§āϪ⧟ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤

Investigation Status

Adv. āĻ…āĻ‚āĻļ⧇ āĻĢāϞ⧇āϰ āĻŽāϤ⧋ āϏāĻ‚āĻ–ā§āϝāĻž āϞ⧇āĻ–āĻž āĻĨāĻžāĻ•āĻžā§Ÿ āĻāϗ⧁āϞ⧋ āφāϗ⧇ āĻ•āϰāĻž āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻ“ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϏāĻŦāϗ⧁āϞ⧋āϕ⧇ āύāϤ⧁āύ āĻ•āϰ⧇ āĻĻ⧇āĻ“ā§ŸāĻž Investigation Order āĻŦāϞāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Confidence: ECG āĻ“ RBS āĻļāύāĻžāĻ•ā§āϤāĻ•āϰāϪ⧇ āĻŽāĻžāĻāĻžāϰāĻŋ āĻĨ⧇āϕ⧇ āωāĻšā§āϚ; āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻĢāϞ⧇āϰ āĻŦā§āϝāĻžāĻ–ā§āϝāĻžā§Ÿ āĻ•āĻŽāĨ¤


đŸŸĸ 7. Prescribed Drug Analysis — MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻŽā§‹āϟ ā§ĒāϟāĻŋ āĻ“āώ⧁āϧ āϞ⧇āĻ–āĻž āφāϛ⧇ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤

SL Brand Name Generic Name Strength
1 Vertina-D Pyridoxine + Doxylamine 10 mg + 10 mg
2 Filfresh Melatonin 3 mg
3 Astagen Astaxanthin 2 mg
4 Bicozin-I Syrup Iron Polymaltose + Vitamin B Complex + Zinc Combination Syrup

āĻ“āώ⧁āϧāϗ⧁āϞ⧋āϰ āύāĻžāĻŽ MedEx-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻŽāĻŋāϞāĻŋā§Ÿā§‡ āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤ āϤ⧃āĻ¤ā§€ā§Ÿ āĻ“ āϚāϤ⧁āĻ°ā§āĻĨ āύāĻžāĻŽā§‡āϰ āĻĒāĻžāĻ  āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻšāϞ⧇āĻ“ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻŽā§‚āϞ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻž āĻ“āώ⧁āϧ⧇āϰ āĻĒā§āϝāĻžāϕ⧇āϟ āĻĻ⧇āĻ–āĻž āωāϚāĻŋāϤāĨ¤


💊 1. Vertina-D Tablet

Brand Information

Information Details
BD Brand Name Vertina-D
Generic Name Pyridoxine Hydrochloride + Doxylamine Succinate
Strength 10 mg + 10 mg
Manufacturer Square Pharmaceuticals PLC
MedEx Therapeutic Class Anti-emetic drugs
Pharmacological Class H1 Antihistamine + Vitamin B6
Unit Price ā§ŗ5.00
Strip Price ā§ŗ50.00 (10 tablets)
Other Strength Vertina-DX 20 mg + 20 mg

MedEx Link: Vertina-D 10 mg + 10 mg

āϤāĻĨā§āϝ āĻ“ āĻŽā§‚āĻ˛ā§āϝ MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€āĨ¤

Use of Purpose — āϕ⧀ āĻ•āĻžāĻœā§‡ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ?

Vertina-D āĻŽā§‚āϞāϤ āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻžāϰ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ“ āĻŦāĻŽāĻŋāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

āĻāϰ āĻĻ⧁āϟāĻŋ āωāĻĒāĻžāĻĻāĻžāύ:

Doxylamine: First-generation H1 antihistamineāĨ¤ āĻāϟāĻŋ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ•āĻŽāĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇ āĻāĻŦāĻ‚ āϘ⧁āĻŽ āϘ⧁āĻŽ āĻ­āĻžāĻŦ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Pyridoxine: Vitamin B6āĨ¤ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

Why Doctor Prescribed It in This Patient?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Vertigo āωāĻ˛ā§āϞ⧇āĻ– āĻĨāĻžāĻ•āĻžā§Ÿ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻšā§ŸāϤ⧋ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻĨāĻžāĻ•āĻž āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āĻŦāĻž āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ•āĻŽāĻžāύ⧋āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻ“āώ⧁āϧāϟāĻŋ āĻĻāĻŋā§Ÿā§‡āϛ⧇āύāĨ¤

āϤāĻŦ⧇ āĻāĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟:

Vertina-D āĻšāϞ⧋ āĻŽā§‚āϞāϤ Nausea and Vomiting of Pregnancy-āĻāϰ āĻ“āώ⧁āϧāĨ¤ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖ Vertigo āĻŦāĻž BPPV-āĻāϰ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύ⧟āĨ¤

āĻ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻāϟāĻŋ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāĻŖ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻĨ⧇āϕ⧇ āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Dose in Prescription

āϞ⧇āĻ–āĻž āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϏāĻŽā§āĻ­āĻŦāϤ ā§§+ā§Ļ+ā§§ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϏāĻŽā§ŸāĻ•āĻžāϞ āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟āĨ¤

āĻāχ āĻ“āώ⧁āϧ⧇āϰ Delayed Release Formulation-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ MedEx-āĻāϰ āύāĻŋ⧟āĻŽāĻŋāϤ āĻĄā§‹āϜ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž āĻāϰ āĻĨ⧇āϕ⧇ āĻ­āĻŋāĻ¨ā§āύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻžāχ āĻšāĻžāϤ⧇ āϞ⧇āĻ–āĻž āĻĄā§‹āϜāϟāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϏāĻ™ā§āϗ⧇ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤

Important Side Effects

  • Drowsiness — āϘ⧁āĻŽ āϘ⧁āĻŽ āĻ­āĻžāĻŦ
  • Dry mouth — āĻŽā§āĻ– āĻļ⧁āĻ•āĻžāύ⧋
  • Dizziness — āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻŦā§‡ā§œā§‡ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇
  • Impaired alertness — āĻŽāύ⧋āϝ⧋āĻ— āĻ“ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻ•āĻŽā§‡ āϝāĻžāĻ“ā§ŸāĻž

āϰ⧋āĻ—ā§€āϰ āφāϗ⧇ āĻĨ⧇āϕ⧇āχ Vertigo āĻĨāĻžāĻ•āĻžā§Ÿ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻāĻŋāĻŽā§āύāĻŋ āĻĒā§œā§‡ āϝāĻžāĻ“ā§ŸāĻžāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžā§œāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Alternative Bangladesh Brands

āĻāĻ•āχ Generic Combination-āĻāϰ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ:

  1. Vomix DR — Beximco
  2. Pregmos — Renata
  3. Novea — Healthcare
  4. Dicliz Plus — Aristopharma
  5. Inmit — Radiant

āĻāϏāĻŦ āĻāĻ•āχ āϧāϰāύ⧇āϰ Generic-āĻāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ; āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻ›āĻžā§œāĻž āĻāĻ•āϟāĻŋāϰ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤ⧇ āφāϰ⧇āĻ•āϟāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤


💊 2. Filfresh 3 mg Tablet

Brand Information

Information Details
BD Brand Name Filfresh
Generic Name Melatonin
Strength 3 mg
Manufacturer Square Pharmaceuticals PLC
MedEx Therapeutic Class Hormone preparations for other uses, Oral nutritional preparations
Pharmacological Class Melatonin receptor agonist / Endogenous pineal hormone
Unit Price ā§ŗ3.01
Strip Price ā§ŗ30.10 (10 tablets)
Available Strength of Filfresh 3 mg

MedEx Link: Filfresh 3 mg Tablet

Use of Purpose — āϕ⧋āύ āϰ⧋āϗ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ?

Melatonin āĻĒā§āϰāϧāĻžāύāϤ Sleep–Wake Cycle āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāϪ⧇ āĻ­ā§‚āĻŽāĻŋāĻ•āĻž āϰāĻžāϖ⧇āĨ¤

āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ:

  1. Sleep-onset difficulty — āϘ⧁āĻŽ āφāϏāϤ⧇ āĻĻ⧇āϰāĻŋ āĻšāĻ“ā§ŸāĻžāĨ¤
  2. Circadian rhythm sleep disorders — āϘ⧁āĻŽā§‡āϰ āϏāĻŽā§ŸāϏ⧂āϚāĻŋāϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤
  3. Jet lag — āĻĻā§€āĻ°ā§āϘ āĻŦāĻŋāĻŽāĻžāύāĻ­ā§āϰāĻŽāϪ⧇āϰ āĻĒāϰ āϘ⧁āĻŽā§‡āϰ āϏāĻŽā§Ÿ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύāĨ¤
  4. āĻ•āĻŋāϛ⧁ āĻŦāĻŋāĻļ⧇āώ Circadian-related insomniaāĨ¤

Why Doctor Prescribed It in This Patient?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ C/C-āϤ⧇ Decreased Sleep āωāĻ˛ā§āϞ⧇āĻ– āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϏ⧁āϤāϰāĻžāĻ‚ āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻ•āĻŽāĻžāύ⧋āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ Filfresh āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤

Prescription–Drug Correlation: High

āĻ…āĻ°ā§āĻĨāĻžā§Ž āϰ⧋āĻ—ā§€āϰ āϞāĻŋāĻ–āĻŋāϤ āĻ…āĻ­āĻŋāϝ⧋āϗ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻāχ āĻ“āώ⧁āϧ⧇āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇āϰ āĻ­āĻžāϞ⧋ āĻŽāĻŋāϞ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϤāĻŦ⧇ Chronic Insomnia-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Melatonin-āϕ⧇ āϏāĻŦ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŦāϞāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤ CBT-I āĻŦāĻž Cognitive Behavioral Therapy for Insomnia āĻ…āϧāĻŋāĻ• āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

Dose in Prescription

āϏāĻŽā§āĻ­āĻŦāϤ ā§Ļ+ā§Ļ+ā§§ āĻ…āĻ°ā§āĻĨāĻžā§Ž āϰāĻžāϤ⧇ āĻāĻ•āϟāĻŋāĨ¤

āϏāĻŽā§ŸāϏ⧀āĻŽāĻž āĻ…āĻ¸ā§āĻĒāĻˇā§āϟāĨ¤

Side Effects

  • Daytime drowsiness — āĻĻāĻŋāύ⧇āϰ āĻŦ⧇āϞāĻž āϘ⧁āĻŽ āϘ⧁āĻŽ āĻ­āĻžāĻŦ
  • Headache — āĻŽāĻžāĻĨāĻžāĻŦā§āϝāĻĨāĻž
  • Dizziness — āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž

Alternative BD Brands

  1. Melafit 3 mg — Beacon
  2. Melato 3 mg — Beximco
  3. Melonin 3 mg — Eskayef

MedEx āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāϗ⧁āϞ⧋ Melatonin-āĻāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄāĨ¤

Clinical Caution: Vertina-D-āĻāϰ Doxylamine āĻāĻŦāĻ‚ Filfresh—āĻĻ⧁āϟāĻŋāχ āĻāĻŋāĻŽā§āύāĻŋ āĻŦāĻžā§œāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĻāϰāĻ•āĻžāϰāĨ¤


💊 3. Astagen 2 mg Capsule

Brand Information

Information Details
BD Brand Name Astagen
Generic Name Astaxanthin
Strength 2 mg
Manufacturer General Pharmaceuticals Ltd.
MedEx Therapeutic Class Supplements & adjuvant therapy
Pharmacological Class Carotenoid antioxidant
Unit Price ā§ŗ12.03
Pack Price ā§ŗ361.00 (30 capsules)
Other Strength Astagen 4 mg

MedEx Link: Astagen 2 mg Capsule

Use of Purpose — āϕ⧋āύ āĻ•āĻžāĻœā§‡ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ?

Astaxanthin āĻāĻ•āϟāĻŋ Carotenoid AntioxidantāĨ¤

āĻāϟāĻŋ Antioxidant Supplement āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻžāϜāĻžāϰāϜāĻžāϤ āĻ•āϰāĻž āĻšā§ŸāĨ¤

MedEx-āĻ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇, āϝ⧇āĻŽāύ:

  • Oxidative stress-related supportive therapy
  • āĻ•āĻŋāϛ⧁ Cardiovascular āĻ“ Inflammatory Condition-āĻ āϏāĻšāĻžā§ŸāĻ• āĻŦā§āϝāĻŦāĻšāĻžāϰ
  • Skin āĻ“ eye health-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ supplementation

āϤāĻŦ⧇ āĻāϏāĻŦ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āωāĻĒāĻ•āĻžāϰ⧇āϰ āĻĒā§āϰāĻŽāĻžāϪ⧇āϰ āĻŽāĻžāύ āĻāĻ• āύ⧟ āĻāĻŦāĻ‚ Astaxanthin āϕ⧋āύ⧋ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ Vertigo treatment āύ⧟āĨ¤

Why Doctor Prescribed It in This Patient?

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻšā§ŸāϤ⧋ Antioxidant āĻŦāĻž general supportive therapy-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻĻāĻŋā§Ÿā§‡āϛ⧇āύāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ Vertigo āĻŦāĻž Insomnia-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ Astaxanthin-āĻāϰ āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻž āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ āύ⧟āĨ¤

Clinical Justification: Uncertain

āϰ⧋āĻ—ā§€āϰ documented findings āĻĻ⧇āϖ⧇ Astagen-āĻāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻĒā§āϰāĻŽāĻžāĻŖ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Important Prescription Verification

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Tab. Astagen āϞ⧇āĻ–āĻž āĻŽāύ⧇ āĻšāϞ⧇āĻ“ MedEx-āĻ Astagen 2 mg Capsule āĻšāĻŋāϏ⧇āĻŦ⧇ āϤāĻžāϞāĻŋāĻ•āĻžāϭ⧁āĻ•ā§āϤāĨ¤

āĻĢāĻžāĻ°ā§āĻŽā§‡āϏāĻŋ āĻĨ⧇āϕ⧇ āĻ“āώ⧁āϧ āύ⧇āĻ“ā§ŸāĻžāϰ āϏāĻŽā§Ÿ āĻāϟāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤


💊 4. Bicozin-I Syrup

Brand Information

Information Details
BD Brand Name Bicozin-I
Generic Name Iron Polymaltose Complex + Vitamin B Complex + Zinc
Manufacturer Square Pharmaceuticals PLC
MedEx Therapeutic Class Iron & Vitamin Combined preparations
Pharmacological Class Iron supplement + Multivitamin + Mineral supplement
Price ā§ŗ60.00 / 100 ml bottle

MedEx Link: Bicozin-I Syrup

Composition — āĻĒā§āϰāϤāĻŋ ā§Ģ āĻŽāĻŋāϞāĻŋāϤ⧇ āωāĻĒāĻžāĻĻāĻžāύ

Generic Component Strength
Elemental Iron 50 mg
Thiamine Hydrochloride (Vitamin B1) 5 mg
Riboflavin (Vitamin B2) 2 mg
Pyridoxine Hydrochloride (Vitamin B6) 2 mg
Nicotinamide (Vitamin B3) 20 mg
Elemental Zinc 10 mg

Use of Purpose — āϕ⧋āύ āϰ⧋āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§Ÿ?

  1. Iron deficiency — āĻ†ā§Ÿāϰāύ⧇āϰ āϘāĻžāϟāϤāĻŋāĨ¤
  2. Iron deficiency anemia — āĻ†ā§Ÿāϰāύ⧇āϰ āϘāĻžāϟāϤāĻŋāϜāύāĻŋāϤ āϰāĻ•ā§āϤāĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻžāĨ¤
  3. Vitamin B deficiency — āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ-āĻāϰ āϘāĻžāϟāϤāĻŋāĨ¤
  4. Zinc deficiency — āϜāĻŋāĻ‚āϕ⧇āϰ āϘāĻžāϟāϤāĻŋāĨ¤
  5. Nutritional deficiency — āĻĒ⧁āĻˇā§āϟāĻŋ āωāĻĒāĻžāĻĻāĻžāύ⧇āϰ āϘāĻžāϟāϤāĻŋāĨ¤

Why Doctor Prescribed It in This Patient?

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻšā§ŸāϤ⧋ āĻĒ⧁āĻˇā§āϟāĻŋāϰ āϘāĻžāϟāϤāĻŋ āĻĒā§‚āϰāĻŖ āĻŦāĻž āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻžāϰ āϏāĻšāĻžā§ŸāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻāĻŋā§Ÿā§‡āϛ⧇āύāĨ¤

āϤāĻŦ⧇ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Iron deficiency āĻŦāĻž Vitamin deficiency-āĻāϰ āύāĻŋāĻļā§āϚāĻŋāϤ Diagnosis āύ⧇āχāĨ¤

āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ Bicozin-I-āϤ⧇ Iron āφāϛ⧇āĨ¤ āϤāĻžāχ āĻ†ā§Ÿāϰāύ⧇āϰ āϘāĻžāϟāϤāĻŋ āύāĻž āĻĨāĻžāĻ•āϞ⧇ āĻĻā§€āĻ°ā§āϘāĻĻāĻŋāύ āĻāϟāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§ŸāϤāĻž āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

Dose in Prescription

āϏāĻŽā§āĻ­āĻŦāϤ ⧍ āϚāĻžāĻŽāϚ āϞ⧇āĻ–āĻž āφāϛ⧇āĨ¤

āĻ•āϤāĻŦāĻžāϰ āĻāĻŦāĻ‚ āĻ•āϤāĻĻāĻŋāύ āϖ⧇āϤ⧇ āĻšāĻŦ⧇, āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟āĨ¤

Alternative BD Brands

āĻāĻ•āχ Generic Combination-āĻāϰ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ:

  1. Beconex ZI — Renata
  2. Biozinc-I — Ibn Sina
  3. Supra-Z — Drug International
  4. Vitonic — Beximco
  5. Feziplex — ACME

Important: Bicozin āĻāĻŦāĻ‚ Bicozin-I āĻāĻ• āύ⧟āĨ¤ Bicozin-I-āϤ⧇ Iron āĻ°ā§Ÿā§‡āϛ⧇, āĻ•āĻŋāĻ¨ā§āϤ⧁ āϏāĻžāϧāĻžāϰāĻŖ Bicozin-āĻāϰ āωāĻĒāĻžāĻĻāĻžāύ Vitamin B Complex + ZincāĨ¤


🟡 8. My Clinical Working Assessment

A. Doctor’s Diagnosis — āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰ⧋āĻ—āύāĻŋāĻ°ā§āϪ⧟

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āφāϞāĻžāĻĻāĻž āϕ⧋āύ⧋ āĻ¸ā§āĻĒāĻˇā§āϟ Dx: āϞ⧇āĻ–āĻž āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤

āϤāĻŦ⧇ C/C āĻ“ āĻĒā§āϰāĻĻāĻ¤ā§āϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āύāĻŋāĻšā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϗ⧁āϞ⧋āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ•āϰāϛ⧇āύ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤

Probable Clinical Problem āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ Confidence
Vertigo āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž 98%
Sleep Disturbance āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž 98%
Nutritional deficiency āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻĒ⧁āĻˇā§āϟāĻŋāϰ āϘāĻžāϟāϤāĻŋ 40%

āĻāĻ–āĻžāύ⧇ Nutritional deficiency āϕ⧇āĻŦāϞ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻĻ⧇āĻļā§āϝ; āĻāϟāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤ Diagnosis āύ⧟āĨ¤

B. My Working Clinical Assessment

Primary Problem: Undifferentiated Vertigo

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āĻāĻ–āύ⧋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āĻšā§ŸāύāĻŋ āĻāĻŽāύ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

āĻāϟāĻŋāχ āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϝ⧁āĻ•ā§āϤāĻŋāϏāĻ‚āĻ—āϤ Working DiagnosisāĨ¤

Confidence: 95% āϝ⧇ āϰ⧋āĻ—ā§€āϰ documented clinical problem VertigoāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ Vertigo-āĻāϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āĻŖā§Ÿā§‡āϰ āϜāĻ¨ā§āϝ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āύ⧇āχāĨ¤

Possible Peripheral Vestibular Disorder

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāύ⧇āϰ āϭ⧇āϤāϰ⧇āϰ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝ āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŖāĻ•āĻžāϰ⧀ āĻ…āĻ™ā§āĻ— āĻŦāĻž Vestibular Nerve-āĻāϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

Confidence: Approximately 55% — provisional clinical suspicion, not a validated probability.

āĻ•āĻžāϰāĻŖ:

  • Vertigo āϞ⧇āĻ–āĻž āĻ°ā§Ÿā§‡āϛ⧇āĨ¤
  • āĻ•āĻŋāĻ¨ā§āϤ⧁ Positional Trigger āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤
  • Nystagmus-āĻāϰ āϤāĻĨā§āϝ āύ⧇āχāĨ¤
  • Ear examination āĻŦāĻž vestibular assessment āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤
  • Central neurological causes exclusion āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇ āĻ•āĻŋ āύāĻž āϜāĻžāύāĻž āύ⧇āχāĨ¤

Associated Problem: Sleep Disturbance

āĻŦāĻžāĻ‚āϞāĻž: āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

Confidence: 98% — documented symptom.

Insomnia Disorder āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āφāϰāĻ“ āχāϤāĻŋāĻšāĻžāϏ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Additional Clinical Findings

1. Raised Blood Pressure Reading — āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āϰāĻŋāĻĄāĻŋāĻ‚: 144/99 mmHg

Confidence: 98%āĨ¤

2. Mild Tachycardia — āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āĻĻā§āϰ⧁āϤ: 103/min

Confidence: 98%āĨ¤

āĻāχ āĻĻ⧁āϟāĻŋ finding āωāĻĒ⧇āĻ•ā§āώāĻž āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤


9. Differential Diagnosis — āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰ⧋āĻ—āϏāĻŽā§‚āĻš

Differential Diagnosis āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻŦ⧈āĻļāĻŋāĻˇā§āĻŸā§āϝ
BPPV āĻŽāĻžāĻĨāĻžāϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇ āĻšāĻ āĻžā§Ž āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻ…āĻ˛ā§āĻĒ āϏāĻŽā§Ÿā§‡āϰ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤ āĻ˜ā§‚āĻ°ā§āĻŖāύ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ
Vestibular Neuritis āĻ­āĻžāϰāϏāĻžāĻŽā§āϝ⧇āϰ āĻ¸ā§āύāĻžā§Ÿā§āϤ⧇ āĻĒā§āϰāĻĻāĻžāĻšāϜāύāĻŋāϤ āϏāĻŽāĻ¸ā§āϝāĻž āϘāĻŖā§āϟāĻž āĻĨ⧇āϕ⧇ āĻĻāĻŋāύāĻŦā§āϝāĻžāĻĒā§€ āϤ⧀āĻŦā§āϰ Vertigo
MÊnière’s Disease āĻ…āĻ¨ā§āϤāσāĻ•āĻ°ā§āϪ⧇āϰ āĻāĻ•āϟāĻŋ āϰ⧋āĻ— Vertigo + Tinnitus + Fluctuating Hearing Loss
Vestibular Migraine āĻŽāĻžāχāĻ—ā§āϰ⧇āύ-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻŽāĻžāχāĻ—ā§āϰ⧇āύ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ‚ āĻŦāĻžāϰāĻŦāĻžāϰ Vertigo
Orthostatic Hypotension āĻĻāĻžāρ⧜āĻžāϞ⧇ āϰāĻ•ā§āϤāϚāĻžāĻĒ āĻ•āĻŽā§‡ āϝāĻžāĻ“ā§ŸāĻž āĻļā§‹ā§ŸāĻž āĻŦāĻž āĻŦāϏāĻž āĻĨ⧇āϕ⧇ āĻĻāĻžāρ⧜āĻžāϞ⧇ āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻ•āĻž āϞāĻžāĻ—āĻž
Cardiac Arrhythmia āĻšā§ƒāĻĻā§â€ŒāĻ¸ā§āĻĒāĻ¨ā§āĻĻāύ⧇āϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ›āĻ¨ā§āĻĻ Palpitation, presyncope āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻ•āĻž āϞāĻžāĻ—āĻž
Central Vertigo āĻŽāĻ¸ā§āϤāĻŋāĻˇā§āϕ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϜāύāĻŋāϤ Vertigo Neurological signs āĻŦāĻž āϗ⧁āϰ⧁āϤāϰ gait instability āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇

Stroke/TIA-āĻāϰ āĻŽāϤ⧋ āĻŦāĻŋāĻĒāĻœā§āϜāύāĻ• āĻ•āĻžāϰāĻŖāϗ⧁āϞ⧋ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻšāĻ āĻžā§Ž āĻļ⧁āϰ⧁ āĻšāĻ“ā§ŸāĻž āĻāĻ•āϟāĻžāύāĻž Vertigo-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻšāĻžāρāϟāϤ⧇ āύāĻž āĻĒāĻžāϰāĻž, āĻĻā§āĻŦ⧈āϤ āĻĻ⧃āĻˇā§āϟāĻŋ, āĻ•āĻĨāĻž āϜ⧜āĻŋā§Ÿā§‡ āϝāĻžāĻ“ā§ŸāĻž, āĻšāĻžāϤ-āĻĒāĻž āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āĻŦāĻž āύāϤ⧁āύ āϤ⧀āĻŦā§āϰ āĻŽāĻžāĻĨāĻžāĻŦā§āϝāĻĨāĻž āĻĨāĻžāĻ•āϞ⧇ āϜāϰ⧁āϰāĻŋ āĻšāĻžāϏāĻĒāĻžāϤāĻžāϞ⧇ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


10. Doctor’s Diagnosis vs My Diagnosis

āĻŦāĻŋāώ⧟ Prescribing Doctor’s Assessment My Assessment
Vertigo āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇ āĻāĻ•āĻŽāϤ
Sleep problem āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇ āĻāĻ•āĻŽāϤ
BPPV āĻ¸ā§āĻĒāĻˇā§āϟ āϞ⧇āĻ–āĻž āύ⧇āχ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ›āĻžā§œāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟
Hypertension Dx āϞ⧇āĻ–āĻž āύ⧇āχ Elevated BP; Hypertension confirmation required
Tachycardia Pulse 103/min āϞ⧇āĻ–āĻž āφāϛ⧇ Mild tachycardia
Vitamin deficiency Dx āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟ Laboratory confirmation required
Central neurological cause Assessment āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇

Are Both Diagnoses Similar?

āĻšā§āϝāĻžāρ, āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āĻĒāĻ°ā§āϝāĻžā§Ÿā§‡ āĻĻ⧁āϟāĻŋāϰ āĻŽāĻ§ā§āϝ⧇ āĻŽāĻŋāϞ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Vertigo āĻ“ Sleep Disturbance āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤ āφāĻŽāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āĻ“ āĻāϗ⧁āϞ⧋āχ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

āϤāĻŦ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ āĻšāϞ⧋:

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Vertigo-āĻāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ Etiology āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤ āφāĻŽāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āĻ“ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāĻŖ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϏāĻŽā§āĻ­āĻŦ āĻšā§ŸāύāĻŋāĨ¤

āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇ BP 144/99 āĻāĻŦāĻ‚ Pulse 103/min āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ Findings, āϝ⧇āϗ⧁āϞ⧋āϰ Follow-up āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Three Major Clinical Concerns

1. Vertigo-āĻāϰ āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āϪ⧟ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻšā§ŸāύāĻŋāĨ¤

BPPV āĻšāϞ⧇ repositioning manoeuvre āĻ•āĻžāĻ°ā§āϝāĻ•āϰ; āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇ Central Vertigo āĻšāϞ⧇ āϜāϰ⧁āϰāĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

2. Vertina-D āĻ“ Filfresh āĻāĻ•āϏāĻ™ā§āϗ⧇ āĻāĻŋāĻŽā§āύāĻŋ āĻŦāĻžā§œāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āφāϗ⧇ āĻĨ⧇āϕ⧇āχ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āĻ…āĻ­āĻŋāϝ⧋āĻ— āĻĨāĻžāĻ•āĻžā§Ÿ Fall Risk āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

3. Astagen āĻ“ Bicozin-I-āĻāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§ŸāϤāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤

āϰ⧋āĻ—ā§€āϰ āϜāĻ¨ā§āϝ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āωāĻĒāĻ•āĻžāϰ⧇āϰ āĻĒā§āϰāĻŽāĻžāĻŖ āĻŦāĻž Nutritional Deficiency-āĻāϰ Diagnosis āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤


āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻšāϞ⧋ Clinical AssessmentāĨ¤

A. Clinical Examination

  1. Dix–Hallpike Test: BPPV āĻļāύāĻžāĻ•ā§āϤ⧇āϰ āϜāĻ¨ā§āϝ, āωāĻĒāϝ⧁āĻ•ā§āϤ Positional Vertigo āĻĨāĻžāĻ•āϞ⧇āĨ¤
  2. Neurological Examination: Central cause-āĻāϰ āϞāĻ•ā§āώāĻŖ āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤
  3. Nystagmus Examination: āĻšā§‹āϖ⧇āϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āύ⧜āĻžāϚ⧜āĻž āĻĒāϰ⧀āĻ•ā§āώāĻžāĨ¤
  4. Orthostatic BP and Pulse: āĻļā§‹ā§ŸāĻž āĻ“ āĻĻāĻžāρ⧜āĻžāύ⧋ āĻ…āĻŦāĻ¸ā§āĻĨāĻžā§Ÿ BP āĻāĻŦāĻ‚ PulseāĨ¤
  5. Otoscopy and Hearing Assessment: āĻ•āĻžāύ⧇āϰ āϰ⧋āĻ— āĻŦāĻž āĻļā§āϰāĻŦāĻŖ āϏāĻŽāĻ¸ā§āϝāĻž āύāĻŋāĻ°ā§āϪ⧟āĨ¤

HINTS āĻĒāϰ⧀āĻ•ā§āώāĻž āĻļ⧁āϧ⧁ āωāĻĒāϝ⧁āĻ•ā§āϤ Acute Vestibular Syndrome-āĻ āĻĒā§āϰāĻļāĻŋāĻ•ā§āώāĻŋāϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻ•āϰāĻŦ⧇āύāĨ¤

B. Laboratory Investigations

āϰ⧋āĻ—ā§€āϰ āχāϤāĻŋāĻšāĻžāϏ, āĻĒāϰ⧀āĻ•ā§āώāĻž āĻāĻŦāĻ‚ āĻĒā§‚āĻ°ā§āĻŦ⧇āϰ āϰāĻŋāĻĒā§‹āĻ°ā§āϟ āĻ…āύ⧁āϝāĻžā§Ÿā§€:

Investigation Why Needed
CBC Anemia āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϰāĻ•ā§āϤ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ
Fasting Glucose / HbA1c Diabetes screening, āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€
Serum Electrolytes Sodium, Potassium āχāĻ¤ā§āϝāĻžāĻĻāĻŋāϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āϤāĻž
Serum Creatinine/eGFR Kidney Function
TSH Thyroid Disorder āϏāĻ¨ā§āĻĻ⧇āĻš āĻĨāĻžāĻ•āϞ⧇
Serum Ferritin Iron deficiency āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇
ECG / Holter ECG Palpitation, unexplained tachycardia āĻŦāĻž intermittent arrhythmia āϏāĻ¨ā§āĻĻ⧇āĻšā§‡
ABPM/HBPM Hypertension āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇

MRI Brain: āϏāĻŦāĻžāϰ āϜāĻ¨ā§āϝ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āύ⧟āĨ¤ Central Neurological Cause āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ MRI āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤


12. Bangladesh-Available Drugs for Vertigo

āύāĻŋāĻšā§‡āϰ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāĨ¤ āĻāϗ⧁āϞ⧋ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻ•āĻžāϰāϪ⧇āϰ Vertigo āĻŦāĻž associated nausea-āϤ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰāĻž āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āĻāϟāĻŋ āϰ⧋āĻ—ā§€āϕ⧇ āϏāĻŦ āĻ“āώ⧁āϧ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϤāĻžāϞāĻŋāĻ•āĻž āύ⧟āĨ¤ āϰ⧋āϗ⧇āϰ āĻĒā§āϰāĻ•ā§ƒāϤāĻŋ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ“āώ⧁āϧ āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

1. Betahistine Dihydrochloride

Bangladesh Brands: Betatin, Menaril, Vectra, Vertinor, VesercāĨ¤

MedEx Therapeutic Class: Drugs used in meniere’s diseases.

Pharmacological Class: Histamine analogueāĨ¤

Used For: MÊnière’s disease-related Vertigo āĻāĻŦāĻ‚ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

āĻŦāĻžāĻ‚āϞāĻžā§Ÿ: āĻ•āĻžāύ⧇āϰ āϭ⧇āϤāϰ⧇āϰ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝāϜāύāĻŋāϤ āĻ•āĻŋāϛ⧁ āϏāĻŽāĻ¸ā§āϝāĻžā§Ÿ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻ•āĻŽāĻžāϤ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

MedEx: Betahistine — Available Brands

2. Cinnarizine

Bangladesh Brands: Cinaron, Cinazin, Cinarin, ZincināĨ¤

MedEx Therapeutic Class: Anti vertigo drugs.

Pharmacological Class: Antihistamine with calcium-channel blocking propertiesāĨ¤

Used For: āĻ•āĻŋāϛ⧁ Peripheral Vestibular Disorder āĻāĻŦāĻ‚ Motion SicknessāĨ¤

āĻŦāĻžāĻ‚āϞāĻžā§Ÿ: āĻ•āĻžāύ⧇āϰ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝāϜāύāĻŋāϤ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻ“ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ•āĻŽāĻžāϤ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻšā§ŸāĨ¤

MedEx: Cinnarizine — Generic Information

3. Meclizine Hydrochloride

Bangladesh Brands: Avert, Meczin, Clizin, MelizināĨ¤

MedEx Therapeutic Class: Anti-emetic drugs.

Pharmacological Class: First-generation H1 antihistamineāĨ¤

Used For: Motion sickness āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ Vestibular Disorder-āĻāϰ āωāĻĒāϏāĻ°ā§āĻ— āĻ•āĻŽāĻžāϤ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻžā§Ÿ: āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ“ āϚāϞāĻžāϚāϞāϜāύāĻŋāϤ āĻ…āϏ⧁āĻ¸ā§āĻĨāϤāĻžā§Ÿ āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡ā§ŸāĻžāĻĻāĻŋ āωāĻĒāϏāĻ°ā§āĻ— āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāϪ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§ŸāĨ¤

MedEx: Meclizine — Available Brands

4. Prochlorperazine Maleate

Bangladesh Brands: Stemetil, Vergon, Promtil, VertiganāĨ¤

MedEx Therapeutic Class: Anti vertigo drugs, Anti-emetic drugs.

Pharmacological Class: Phenothiazine derivative / Dopamine D2 receptor antagonistāĨ¤

Used For: Severe nausea, vomiting āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ Vestibular Vertigo-āĻāϰ āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

āĻŦāĻžāĻ‚āϞāĻžā§Ÿ: āϤ⧀āĻŦā§āϰ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ“ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āωāĻĒāϏāĻ°ā§āĻ— āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡ā§ŸāĻžāĻĻ⧇ āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

MedEx: Prochlorperazine — Available Brands

5. Meclizine + Pyridoxine

Bangladesh Brands: Mecliz Plus, Acliz Plus, AnvertāĨ¤

MedEx Therapeutic Class: Anti-emetic drugs.

Pharmacological Class: H1 antihistamine + Vitamin B6āĨ¤

Used For: Vestibular Disorder-associated Vertigo, nausea āĻ“ vomiting-āĻāϰ āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

MedEx: Meclizine + Pyridoxine

Important Guideline Note

āϝāĻĻāĻŋ āϰ⧋āĻ—ā§€āϰ BPPV āύāĻŋāĻļā§āϚāĻŋāϤ āĻšā§Ÿ, āϤāĻžāĻšāϞ⧇ āύāĻŋ⧟āĻŽāĻŋāϤ Antihistamine āĻŦāĻž Vestibular Suppressant āĻĻ⧇āĻ“ā§ŸāĻžāχ āĻĒā§āϰāϧāĻžāύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύ⧟āĨ¤

AAO-HNS Guideline āĻ…āύ⧁āϝāĻžā§Ÿā§€ Posterior Canal BPPV-āĻāϰ āϜāĻ¨ā§āϝ āωāĻĒāϝ⧁āĻ•ā§āϤ Epley Manoeuvre āĻšāϞ⧋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

āĻāϟāĻŋ trained clinician āĻĻā§āĻŦāĻžāϰāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤


13. Management & Treatment Plan

Step 1 — Establish the Cause of Vertigo

āĻĒā§āϰāĻĨāĻŽā§‡ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇:

  • āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻ•āϤāĻĻāĻŋāύ āϧāϰ⧇ āĻšāĻšā§āϛ⧇?
  • āĻĒā§āϰāϤāĻŋāĻŦāĻžāϰ āĻ•āϤāĻ•ā§āώāĻŖ āĻĨāĻžāϕ⧇?
  • āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āϏāĻ™ā§āϗ⧇ Hearing Loss āĻŦāĻž Tinnitus āφāϛ⧇ āĻ•āĻŋ āύāĻž?
  • Position āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇āϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽā§āĻĒāĻ°ā§āĻ• āφāϛ⧇ āĻ•āĻŋ āύāĻž?
  • Neurological Red Flags āφāϛ⧇ āĻ•āĻŋ āύāĻž?

Step 2 — Manage According to Diagnosis

If BPPV is confirmed:

  • Canalith Repositioning Manoeuvre, āϝ⧇āĻŽāύ EpleyāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ Vestibular RehabilitationāĨ¤
  • Routine Vestibular Suppressant āĻā§œāĻŋā§Ÿā§‡ āϚāϞāĻžāĨ¤

If MÊnière’s Disease is suspected:

  • ENT AssessmentāĨ¤
  • AudiometryāĨ¤
  • āϰ⧋āĻ— āĻ…āύ⧁āϝāĻžā§Ÿā§€ Betahistine āĻŦāĻž āĻ…āĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

If Vestibular Neuritis is suspected:

  • Central Cause āĻŦāĻžāĻĻ āĻĻ⧇āĻ“ā§ŸāĻžāĨ¤
  • āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡ā§ŸāĻžāĻĻāĻŋ Symptomatic TreatmentāĨ¤
  • Vestibular RehabilitationāĨ¤
  • Selected acute cases-āĻ specialist assessment āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

Step 3 — Assess Sleep Disturbance

  • Sleep HistoryāĨ¤
  • āύāĻŋ⧟āĻŽāĻŋāϤ āϘ⧁āĻŽā§‡āϰ āϏāĻŽā§ŸāϏ⧂āϚāĻŋāĨ¤
  • Caffeine āĻ“ stimulant intake āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤
  • Anxiety āĻŦāĻž Sleep Apnea-āĻāϰ āĻŽāϤ⧋ āĻ•āĻžāϰāĻŖ āĻ…āύ⧁āϏāĻ¨ā§āϧāĻžāύāĨ¤
  • Persistent Insomnia āĻšāϞ⧇ CBT-I āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

Step 4 — Recheck Blood Pressure

  • āϏāĻ āĻŋāĻ• āĻĒāĻĻā§āϧāϤāĻŋāϤ⧇ āĻĒ⧁āύāϰāĻžā§Ÿ BP āĻŽāĻžāĻĒāĻžāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ⧇ ā§­ āĻĻāĻŋāύ⧇āϰ Home BP MonitoringāĨ¤
  • Hypertension āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāϞ⧇ cardiovascular risk āĻāĻŦāĻ‚ comorbidity āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

NICE NG136 āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāĻ•āϟāĻŋ Clinic BP Reading āĻĻāĻŋā§Ÿā§‡ āĻ¸ā§āĻĨāĻžā§Ÿā§€ Hypertension āύāĻŋāĻ°ā§āϪ⧟ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤

Step 5 — Medication Review

āĻŦāĻ°ā§āϤāĻŽāĻžāύ Prescribed Drugs-āĻāϰ āĻŽāĻ§ā§āϝ⧇:

  • Vertina-D-āĻāϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āĻāĻŦāĻ‚ dose āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻžāĨ¤
  • Filfresh-āĻāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ, āϏāĻŽā§ŸāĻ•āĻžāϞ āĻāĻŦāĻ‚ daytime sedation āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤
  • Astagen-āĻāϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻĒāĻ°ā§āϝāĻžāϞ⧋āϚāύāĻžāĨ¤
  • Bicozin-I-āĻāϰ āϜāĻ¨ā§āϝ Iron āĻŦāĻž Nutritional Deficiency āφāϛ⧇ āĻ•āĻŋ āύāĻž āĻĻ⧇āĻ–āĻžāĨ¤

14. Referral — āϕ⧋āύ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āĻ•āĻžāϛ⧇ āĻĒāĻžāĻ āĻžāĻŦ⧇āύ?

Primary Referral: ENT Specialist

Department: ENT / Otolaryngology

āĻŦāĻžāĻ‚āϞāĻž: āύāĻžāĻ•-āĻ•āĻžāύ-āĻ—āϞāĻž āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĨ¤

Reason: Persistent or recurrent Vertigo requiring evaluation for vestibular disorders.

āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇:

  • Positional Vertigo
  • Tinnitus
  • Hearing Loss
  • Suspected MÊnière’s Disease
  • Suspected BPPV

Neurologist Referral

āϝāĻ–āύ:

  • Central Vertigo āϏāĻ¨ā§āĻĻ⧇āĻš āĻšā§ŸāĨ¤
  • Vestibular Migraine āϏāĻ¨ā§āĻĻ⧇āĻš āĻšā§ŸāĨ¤
  • Neurological Symptoms āĻĨāĻžāϕ⧇āĨ¤
  • Vertigo-āĻāϰ āĻ•āĻžāϰāĻŖ āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟ āĻāĻŦāĻ‚ āϞāĻ•ā§āώāĻŖ āĻ…āĻŦā§āϝāĻžāĻšāϤ āĻĨāĻžāϕ⧇āĨ¤

Stroke-āĻāϰ Red Flag āĻĨāĻžāĻ•āϞ⧇ Routine Neurology Appointment āύ⧟; āϏāϰāĻžāϏāϰāĻŋ Emergency Department-āĻ āĻĒāĻžāĻ āĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤

Medicine Specialist

BP 144/99 mmHg āĻāĻŦāĻ‚ Pulse 103/min-āĻāϰ āĻ•āĻžāϰāĻŖ āĻ“ āĻā§āρāĻ•āĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āϰ āϜāĻ¨ā§āϝ Medicine Specialist-āĻ“ āωāĻĒāϝ⧁āĻ•ā§āϤāĨ¤


15. Prescription Diagnosis Note — Clinically āϕ⧀ āϞāĻŋāĻ–āĻŦ⧇āύ?

āĻŦāĻ°ā§āϤāĻŽāĻžāύ āϤāĻĨā§āϝ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āĻ—ā§āϰāĻšāĻŖāϝ⧋āĻ—ā§āϝ Working Diagnosis:

Suggested Clinical Diagnosis

Dx:

1. Vertigo — Etiology under evaluation (R42)

āĻŦāĻžāĻ‚āϞāĻž: āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž — āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āϪ⧟āĻžāϧ⧀āύāĨ¤

2. Sleep Disturbance

āĻŦāĻžāĻ‚āϞāĻž: āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

3. Elevated Blood Pressure Reading — R03.0

āĻŦāĻžāĻ‚āϞāĻž: āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āϰāĻŋāĻĄāĻŋāĻ‚; Hypertension āĻāĻ–āύ⧋ āύāĻŋāĻļā§āϚāĻŋāϤ āύ⧟āĨ¤

4. Mild Tachycardia (Pulse 103/min)

āĻŦāĻžāĻ‚āϞāĻž: āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āĻĻā§āϰ⧁āϤāĨ¤

Concise Prescription Version

Working Dx: Vertigo (etiology undetermined) with sleep disturbance; raised BP reading and mild tachycardia.

āĻŦāĻžāĻ‚āϞāĻž: āĻ•āĻžāϰāĻŖ āĻ…āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āϏāĻ™ā§āϗ⧇ āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž, āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āϰāĻŋāĻĄāĻŋāĻ‚ āĻāĻŦāĻ‚ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āĻĻā§āϰ⧁āϤ āĻĒāĻžāϞāϏāĨ¤

āĻāĻ–āύāχ BPPV, MÊnière’s Disease, Chronic Insomnia āĻŦāĻž Established Hypertension āϞāĻŋāϖ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āϝāĻĨāĻžāϝāĻĨ āύ⧟āĨ¤


16. Referral Note for Prescription

To: Consultant, ENT / Otolaryngology

Clinical Note:

Patient aged approximately 50 years presenting with vertigo and reduced sleep. Recorded BP 144/99 mmHg and pulse 103/min. Kindly evaluate for peripheral vestibular pathology, including BPPV and other causes of vertigo, and advise further management.

āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ:

āφāύ⧁āĻŽāĻžāύāĻŋāĻ• ā§Ģā§Ļ āĻŦāĻ›āϰ āĻŦ⧟āϏ⧀ āϰ⧋āĻ—ā§€ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻ“ āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϰ āĻ…āĻ­āĻŋāϝ⧋āĻ— āύāĻŋā§Ÿā§‡ āĻāϏ⧇āϛ⧇āύāĨ¤ āϰāĻ•ā§āϤāϚāĻžāĻĒ ā§§ā§Ēā§Ē/⧝⧝ mmHg āĻāĻŦāĻ‚ āĻĒāĻžāϞāϏ ā§§ā§Ļā§Š/min āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϛ⧇āĨ¤ āϰ⧋āĻ—ā§€āϰ āĻ•āĻžāύ⧇āϰ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝāϜāύāĻŋāϤ āϏāĻŽāĻ¸ā§āϝāĻž, BPPV āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ•āĻžāϰāĻŖ āύāĻŋāĻ°ā§āϪ⧟ āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āϜāĻ¨ā§āϝ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻ•āĻžāĻŽā§āϝāĨ¤


17. Overview / Summary — āϏāĻžāϰāϏāĻ‚āĻ•ā§āώ⧇āĻĒ

Clinical Finding Final Assessment Confidence
Vertigo Documented Clinical Symptom 98%
Reduced Sleep Documented Clinical Symptom 98%
Elevated BP 144/99 mmHg 98%
Mild Tachycardia Pulse 103/min 98%
Peripheral Vestibular Disease Possible 55%
Specific BPPV Diagnosis Insufficient evidence Low
Established Hypertension Not confirmed Low
Nutritional Deficiency Not established Low

Confidence Scores are subjective assessments of the available documentation, not statistically validated diagnostic probabilities.

Final Clinical Conclusion

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϞ⧋ Vertigo āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž āĻāĻŦāĻ‚ Sleep Disturbance āĻŦāĻž āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤

āϏāĻ™ā§āϗ⧇ Elevated Blood Pressure (144/99 mmHg) āĻ“ Mild Tachycardia (103/min) āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ Vestibular Disorder, āϝ⧇āĻŽāύ BPPV, āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻžāϰ āĻŽāϤ⧋ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āύ⧇āχāĨ¤

My Final Working Diagnosis: Undifferentiated Vertigo with Associated Sleep Disturbance, Elevated BP Reading and Mild Tachycardia.


18. Actionable Plan — āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻ•āϰāĻŖā§€ā§Ÿ

  1. āϰ⧋āĻ—ā§€āϰ Vertigo-āĻāϰ āϏāĻŽā§ŸāĻ•āĻžāϞ, Trigger āĻāĻŦāĻ‚ Associated Symptoms āϏāĻ‚āĻ—ā§āϰāĻš āĻ•āϰ⧁āύāĨ¤
  2. Neurological Examination āĻ“ āωāĻĒāϝ⧁āĻ•ā§āϤ Vestibular Examination āĻ•āϰ⧁āύāĨ¤
  3. BP āĻĒ⧁āύāϰāĻžā§Ÿ āĻŽā§‡āĻĒ⧇ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ ABPM/HBPM āĻ•āϰ⧁āύāĨ¤
  4. ECG āĻ“ CBC-āϏāĻš āĻĒā§‚āĻ°ā§āĻŦ⧇āϰ āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞ⧋āϰ āĻŽā§‚āϞ āϰāĻŋāĻĒā§‹āĻ°ā§āϟ āϏāĻ‚āĻ—ā§āϰāĻš āĻ•āϰ⧁āύāĨ¤
  5. Vertina-D, Filfresh, Astagen āĻ“ Bicozin-I-āĻāϰ Indication āĻāĻŦāĻ‚ Dose āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰ⧁āύāĨ¤
  6. āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ ENT āĻ“ Medicine Specialist-āĻāϰ āĻ•āĻžāϛ⧇ Refer āĻ•āϰ⧁āύāĨ¤

āĻšāĻ āĻžā§Ž āϤ⧀āĻŦā§āϰ āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āĻšāĻžāρāϟāϤ⧇ āύāĻž āĻĒāĻžāϰāĻž, āĻāĻ•āĻĒāĻžāĻļ āĻĻ⧁āĻ°ā§āĻŦāϞ āĻšāĻ“ā§ŸāĻž, āĻ•āĻĨāĻž āϜ⧜āĻŋā§Ÿā§‡ āϝāĻžāĻ“ā§ŸāĻž, āύāϤ⧁āύ āĻĻā§āĻŦ⧈āϤ āĻĻ⧃āĻˇā§āϟāĻŋ āĻ…āĻĨāĻŦāĻž āĻ…āĻœā§āĻžāĻžāύ āĻšāĻ“ā§ŸāĻžāϰ āĻŽāϤ⧋ āωāĻĒāϏāĻ°ā§āĻ— āĻĨāĻžāĻ•āϞ⧇ āϜāϰ⧁āϰāĻŋ āĻšāĻžāϏāĻĒāĻžāϤāĻžāϞ⧇ āĻĒāĻžāĻ āĻžāύāĨ¤


19. Reference List — Textbook + Guideline + DOI

A. Standard Medical Textbooks

1. Harrison’s Principles of Internal Medicine.

22nd Edition. McGraw Hill, 2025.

Chapter 24: Dizziness and Vertigo.

2. Davidson’s Principles and Practice of Medicine.

25th Edition. Elsevier, 2026.

Chapter 27: Neurology and Stroke Medicine.

3. Katzung’s Basic & Clinical Pharmacology.

16th Edition. McGraw Hill, 2024.

Chapter 16: Histamine, Serotonin, Anti-Obesity Drugs, and the Ergot Alkaloids.

B. International Clinical Guidelines

4. NICE Guideline NG127.

Suspected Neurological Conditions: Recognition and Referral, 2019.

Vertigo, BPPV and Vestibular Migraine assessment.

NICE NG127 Guideline

5. NICE Guideline NG136.

Hypertension in Adults: Diagnosis and Management.

Published 2019; subsequently updated.

NICE NG136 Guideline

6. American Academy of Otolaryngology–Head and Neck Surgery Foundation.

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update), 2017.

DOI: 10.1177/0194599816689667

C. Peer-Reviewed Journals with DOI

7. Edlow JA, et al.

Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department.

Academic Emergency Medicine. 2023;30:442–486.

DOI: 10.1111/acem.14728

8. Qaseem A, et al.

Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.

Annals of Internal Medicine. 2016;165(2):125–133.

DOI: 10.7326/M15-2175

D. Bangladesh Drug Reference

9. MedEx Bangladesh: Drug indications, generic compositions, therapeutic classifications, manufacturers and listed Bangladesh prices.

MedEx Bangladesh


āϏāĻŦāĻļ⧇āώ⧇ āϤāĻŋāύāϟāĻŋ āϤāĻĨā§āϝ āϜāĻžāύāϤ⧇ āϚāĻžāχ:

ā§§. āϰ⧋āĻ—ā§€ āĻĒ⧁āϰ⧁āώ āύāĻžāĻ•āĻŋ āĻŽāĻšāĻŋāϞāĻž?

⧍. āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϟāĻž āĻ•āĻŋ āĻŦāĻŋāĻ›āĻžāύāĻžā§Ÿ āĻĒāĻžāĻļ āĻĢāĻŋāϰāϞ⧇ āĻŦāĻž āĻŽāĻžāĻĨāĻž āύ⧜āĻžāϞ⧇ āĻšā§Ÿ, āύāĻžāĻ•āĻŋ āϏāĻžāϰāĻžāĻ•ā§āώāĻŖ āĻĨāĻžāϕ⧇?

ā§Š. āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻ•āĻŋ āĻ•āĻžāύ⧇ āĻļāĻŦā§āĻĻ, āĻļā§āϰāĻŦāĻŖāĻļāĻ•ā§āϤāĻŋ āĻ•āĻŽā§‡ āϝāĻžāĻ“ā§ŸāĻž, āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻ­āĻžāĻŦ āĻ…āĻĨāĻŦāĻž āĻšāĻžāρāϟāϤ⧇ āĻ­āĻžāϰāϏāĻžāĻŽā§āϝ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž āφāϛ⧇?

āĻāχ āϤāĻĨā§āϝāϗ⧁āϞ⧋ āĻĒ⧇āϞ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ Peripheral Vertigo, BPPV, Vestibular Migraine āĻāĻŦāĻ‚ Central Vertigo-āĻāϰ āĻŽāĻ§ā§āϝ⧇ āφāϰāĻ“ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝāĻ­āĻžāĻŦ⧇ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ āĻ•āϰ⧇ Working Diagnosis āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āϝāĻžāĻŦ⧇āĨ¤

Md.Rafiqul Islam Lipu

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top